58 related articles for article (PubMed ID: 890495)
1. Nigrostriatal loop - from basics and beyond.
Monje MHG; Blesa J
Neurobiol Dis; 2024 Jun; 195():106503. PubMed ID: 38614276
[No Abstract] [Full Text] [Related]
2. Nigral actions of GABA agonists are enhanced by chronic fluphenazine and differentiated by concomitant flurazepam.
Coward DM
Psychopharmacology (Berl); 1982; 76(3):294-8. PubMed ID: 6808554
[TBL] [Abstract][Full Text] [Related]
3. The central GABAergic system and control of food intake under different experimental conditions.
Olgiati VR; Netti C; Guidobono F; Pecile A
Psychopharmacology (Berl); 1980; 68(2):163-7. PubMed ID: 6776560
[TBL] [Abstract][Full Text] [Related]
4. Circling behavior induced by intranigral injections of GABA and muscimol in rats.
Kaakkola S; Kääriäinen I
Psychopharmacology (Berl); 1980; 68(1):31-6. PubMed ID: 6771796
[TBL] [Abstract][Full Text] [Related]
5. Oxolinic acid and diazepam: their reciprocal antagonism in rodents.
Thiébot MH; Kloczko J; Chermat R; Simon P; Soubrié P
Psychopharmacology (Berl); 1980 Jan; 67(1):91-5. PubMed ID: 6768084
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions.
Melamed E; Hefti F; Wurtman RJ
Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4305-9. PubMed ID: 6254020
[TBL] [Abstract][Full Text] [Related]
7. Behavioral differences induced by muscimol selectively injected into pars compacta and pars reticulata of Substantia nigra.
Arnt J; Scheel-Krüger J
Naunyn Schmiedebergs Arch Pharmacol; 1979 Dec; 310(1):43-51. PubMed ID: 575196
[No Abstract] [Full Text] [Related]
8. Baclofen and muscimol: behavioural and neurochemical sequelae of unilateral intranigral administration and effects on 3H-GABA receptor binding.
Waddington JL; Cross AJ
Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):275-80. PubMed ID: 471079
[TBL] [Abstract][Full Text] [Related]
9. Effects of intranigral administration of dopamine agonists and antagonists and baclofen on concentrations of dopac and dopamine in the striatum and substantia nigra of the rat.
Wuerthele SM; Friedle NM; Moore KE
J Neural Transm; 1979; 45(2):117-27. PubMed ID: 469523
[TBL] [Abstract][Full Text] [Related]
10. GABAergic and glycinergic mechanisms within the substantia nigra: pharmacological specificity of dopamine-independent contralateral turning behavior and interactions with other neurotransmitters.
Arnt J; Scheel-Krüger J
Psychopharmacology (Berl); 1979 Apr; 62(3):267-77. PubMed ID: 37544
[TBL] [Abstract][Full Text] [Related]
11. Cataleptic and anticataleptic effects of muscimol and gabaculine injected into globus pallidus and substantia nigra, and interactions with haloperidol or benzodiazepines.
Matsui Y; Kamioka T
Naunyn Schmiedebergs Arch Pharmacol; 1978 Dec; 305(3):219-25. PubMed ID: 33340
[TBL] [Abstract][Full Text] [Related]
12. Lack of involvement of dopaminergic and GABA neurones in the inhbitory effect of harmaline on the activity of striatal cholinergic neurones in the rat.
Javoy F; Euvrard C; Herbet A; Bockaert J; Enjalbert A; Agid Y; Glowinski J
Naunyn Schmiedebergs Arch Pharmacol; 1977 Apr; 297(3):233-9. PubMed ID: 141623
[No Abstract] [Full Text] [Related]
13. Inhibitory mechanisms in the substantia nigra and the dopamine pathway.
Straughan DW; James TA
Int J Neurol; 1979; 13(1-4):81-93. PubMed ID: 122391
[No Abstract] [Full Text] [Related]
14. The role of dopamine in the striatum, with a consideration of thalamic inputs.
McLennan H
Appl Neurophysiol; 1979; 42(1-2):40-2. PubMed ID: 222206
[No Abstract] [Full Text] [Related]
15. The striatum and substantia nigra: a commentary on their relationships.
Dray A
Neuroscience; 1979; 4(10):1407-39. PubMed ID: 233319
[No Abstract] [Full Text] [Related]
16. Functional interaction between rat substantia nigra and striatum: GABA and dopamine interrelation.
Racagni G; Bruno F; Cattabeni F; Maggi A; Di Giulio AM; Parenti M; Groppetti A
Brain Res; 1977 Oct; 134(2):353-8. PubMed ID: 890495
[No Abstract] [Full Text] [Related]
17. The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAergic pathway.
Olianas MC; De Montis GM; Mulas G; Tagliamonte A
Eur J Pharmacol; 1978 Jun; 49(3):233-41. PubMed ID: 566207
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
